FPS
ABMD

Fieldpoint Private Securities’s Abiomed Inc ABMD Stock Holding History

Fieldpoint Private Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Sell
10
-15
-60% -$4.05K ﹤0.01% 1273
2022
Q1 		$8K Buy
25
+15
+150% +$4.62K ﹤0.01% 1169
2021
Q4 		$4K Hold
10
– – ﹤0.01% 1368
2021
Q3 		$3K Hold
10
– – ﹤0.01% 1425
2021
Q2 		$3K Hold
10
– – ﹤0.01% 1355
2021
Q1 		$3K Hold
10
– – ﹤0.01% 1348
2020
Q4 		$3K Buy
+10
New +$2.77K ﹤0.01% 1281

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fieldpoint Private Securities's ABMD Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Abiomed Inc (ABMD) stake by 60% in Q2 2022, selling an estimated $4.05K and leaving 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Fieldpoint Private Securities first reported a position in ABMD in Q4 2020 and has held it in 7 quarters since. The position peaked at $8K in Q1 2022. 495 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Fieldpoint Private Securities held 10 shares of Abiomed Inc worth $2K as of Q2 2022.
  • Fieldpoint Private Securities sold 15 Abiomed Inc shares in Q2 2022, an estimated $4.05K.
  • Abiomed Inc made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1273 holding.
  • Fieldpoint Private Securities first reported a position in Abiomed Inc in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Abiomed Inc position peaked at $8K in Q1 2022.
  • 495 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.